New Delhi | India's exports of generic medicines and medical devices, such as X-ray systems and surgical instruments, will ...

India and the UK have signed a free trade agreement. This deal eliminates duties on generic medicines and medical devices. Indian medical device companies will become more competitive in the UK. The ...

Indian pharmaceutical market saw a late surge in June, with growth during the quarter primarily driven by cardiac, respiratory, CNS, and anti-diabetic therapies, said Emkay Global analysts.

India-UK free trade agreement eliminates tariffs on generic drugs and medical devices, boosting Indian exports to the UK market. This opens significant growth opportunities for Indian pharmaceutical ...

India's pharmaceutical industry boasts global stature as the 'Pharmacy of the World' but faces significant domestic challenges from informal credit systems. Here's why ...

With ₹700 crore in budgetary support, seven CoEs have been established at the National Institutes of Pharmaceutical Education ...

Indian pharma steers towards real-time quality control with automation & IIoT for traceability & regulatory compliance: Nandita Vijayasimha, Bengaluru Thursday, July 24, 2025, 08: ...

India Inc celebrates the India-UK free trade agreement, fostering economic cooperation and opening doors for global ...

Factors impacting Indian pharmaceutical industry: Dr. R. B. Smarta Thursday, November 30, 2017, 08:00 Hrs [IST] The Indian pharmaceutical industry, which is expected to grow over 15 per cent per annum ...

Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth ...

Donald Trump's plan to impose pharma tariffs could hit Indian drugmakers like Biocon, Lupin, and Sun Pharma, with new levies ...

In the summer of 2022, at least 70 children in Gambia died from kidney failure after using cough medicine made by India-based Maiden Pharmaceuticals that contained ethylene glycol and diethylene ...